Thomas Lategan
Algemeen Adviseur bij BRIGHT MINDS BIOSCIENCES INC.
Profiel
Thomas Lategan is currently the Vice President of Regulatory Affairs at Bright Minds Biosciences, Inc. He previously held the same position at The Medicines Co., Actelion Pharmaceuticals US, Inc., Panacos Pharmaceuticals, Inc., and NeurAxon, Inc. He also worked as a Principal at Roche Corp.
Lategan holds a doctorate degree from the University of Oxford and an undergraduate degree from the University of Aberdeen.
Actieve functies van Thomas Lategan
| Bedrijven | Functie | Begin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Algemeen Adviseur | 14-06-2021 |
Eerdere bekende functies van Thomas Lategan
| Bedrijven | Functie | Einde |
|---|---|---|
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Algemeen Adviseur | 01-11-2015 |
| PANACOS PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-09-2008 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Algemeen Adviseur | 01-02-2007 |
| THE MEDICINES COMPANY | Algemeen Adviseur | 01-02-2000 |
| Roche Corp. | Corporate Officer/Principal | - |
Opleiding van Thomas Lategan
| University of Oxford | Doctorate Degree |
| University of Aberdeen | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
| Roche Corp. |